Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Functional movement disorders in U.S. veterans: Psychiatric comorbidity and health care utilization.

Mack J, Quinn JF, Lobb BM, O'Connor S.

Mov Disord. 2019 May;34(5):755-756. doi: 10.1002/mds.27650. Epub 2019 Feb 27. No abstract available.

PMID:
30812060
2.

Assessment of an Objective Method of Dyskinesia Measurement in Parkinson's Disease.

Chung KA, Lobb BM, Murchison CF, Mancini M, Hogarth P, Nutt JG.

Mov Disord Clin Pract. 2018 Mar 2;5(2):160-164. doi: 10.1002/mdc3.12583. eCollection 2018 Mar-Apr.

3.

A randomized, controlled pilot study of the effects of vitamin D supplementation on balance in Parkinson's disease: Does age matter?

Hiller AL, Murchison CF, Lobb BM, O'Connor S, O'Connor M, Quinn JF.

PLoS One. 2018 Sep 26;13(9):e0203637. doi: 10.1371/journal.pone.0203637. eCollection 2018.

4.

The use of acetazolamide during pregnancy in intracranial hypertension patients.

Falardeau J, Lobb BM, Golden S, Maxfield SD, Tanne E.

J Neuroophthalmol. 2013 Mar;33(1):9-12. doi: 10.1097/WNO.0b013e3182594001.

PMID:
22635167
5.

Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease.

Chung KA, Lobb BM, Nutt JG, Horak FB.

Neurology. 2010 Oct 5;75(14):1263-9. doi: 10.1212/WNL.0b013e3181f6128c. Epub 2010 Sep 1.

6.

Idiopathic intracranial hypertension in the USA: the role of obesity in establishing prevalence and healthcare costs.

Friesner D, Rosenman R, Lobb BM, Tanne E.

Obes Rev. 2011 May;12(5):e372-80. doi: 10.1111/j.1467-789X.2010.00799.x. Epub 2010 Aug 26. Review.

PMID:
20804521
7.

Objective measurement of dyskinesia in Parkinson's disease using a force plate.

Chung KA, Lobb BM, Nutt JG, McNames J, Horak F.

Mov Disord. 2010 Apr 15;25(5):602-8. doi: 10.1002/mds.22856.

Supplemental Content

Support Center